Supervised machine learning to quantitatively assess the prognostic value of tumor-infiltrating lymphocytes in gastric cancer

Read full text
Authors: Ying‐Hao Luo, Y. Chen, Qian Xu, He Chen, Jingping Yuan, Chunwei Peng, Linwei Wang
Cited by: 0
References: 30

Abstract

BACKGROUND: With growing insights into the tumor immune microenvironment, tumor-infiltrating lymphocytes (TILs) have emerged as key indicators of anti-tumor immunity. Numerous studies highlight their prognostic value in gastric cancer (GC). However, manual or semi-quantitative TIL assessment is time-consuming and poorly reproducible. METHODS: A total of 388 patients with gastric adenocarcinoma were randomly stratified into training and validation cohorts based on TNM stage. QuPath was used to establish an automated workflow for identifying tumor cells, TILs, and other stromal cells in brightfield hematoxylin-eosin (H&E)-stained tissue microarrays (TMAs). TIL-related variables were derived from these classifications. Prognostic significance was assessed using Kaplan-Meier analysis, log-rank tests, and univariable and multivariable Cox proportional hazards models. A nomogram incorporating age, T stage, lymph node metastasis and the proportion of TILs among all cells (pTILs) was built to predict 1- and 3-year overall survival (OS). RESULTS: Higher levels of TILs were associated with improved OS in both cohorts. Multivariate analysis confirmed that pTILs was an important prognostic factor for OS. The nomogram effectively predicted 1-year and 3-year OS. Notably, the nomogram-based risk stratification demonstrated better discriminative ability than TNM stage in distinguishing between low- and middle-risk patients. CONCLUSIONS: This study established a quantitative workflow for TIL assessment in GC. Integrating TIL-related parameters with clinical characteristics enhances risk stratification and may improve individualized prognosis prediction.

Fields of Study & Subjects

Gastric Cancer Management and Outcomes AI in cancer detection Cancer Immunotherapy and Biomarkers

Publication details

Journal / source
BMC Cancer
Volume
26
Issue
1
Pages
248–248
Publication date
19 January 2026
Language
EN